3Lisanby SH,McDonald WM,Massey EW,et al.Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging.J Neural Transm Suppl,1993,40:13 ~ 21
4Hu MT,White SJ,Chaudhuri KR,et al.Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.J Neural Transm,2001,108:571 ~ 580
5Schulz JB,Skalej M,Wedekind D,et al.Magnetic resonance imaging - based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy.Ann Neurol,1999,45:65 ~ 74
6Ghaemi M,Hilker R,Rudolf J,et al.Differentiating multiple system atrophy from Parkinson's disease:contribution of striatal and midbrain MRI volumetry and multi - tracer PET imaging.J Neurol Neurosurg Psychiatry,2002,73:517 ~ 523
7Almeida OP,Burton EJ,McKeith I,et al.MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.Dement Geriatr Cogn Disord,2003,16:57 ~ 63
8Luft AR,Skalej M,Welte D,et al.Reliability and exactness of MRI - based volumetry:a phantom study.J Magn Reson Imaging,1996,6:700 ~ 704
9O'Neill J,Sshuff N,Marks,WJ,et al.Quantitative ^1H magnetic resonance spectroscopy and MRI of Parkinson's disease.Mov Disord,2002,17:917 ~ 927
10Kempster PA,Gibb WR,Stern,GM,et al.Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations.J Neurol Neurosurg Psychiatry,1989,52:72~ 76